Drugs / Umbilical Cord Blood-Derived Stem Cells and Exosomes
Umbilical Cord Blood-Derived Stem Cells and Exosomes
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07304440 | May 2026 → Jun 2028 expected | autism | Adia Med of Winter Park LLC | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Umbilical Cord Blood-Derived Stem Cells and Exosomes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07304440 ↗ |
| Modality | Cell therapy | “an umbilical cord blood-derived stem cell and exosome product” NCT07304440 ↗ |
| Route | Intravenous | “Intravenous infusion of cryopreserved allogeneic umbilical cord blood-derived product containing viable mononuclear cells (including hematopoietic and mesenchymal stem/stromal...” NCT07304440 ↗ |